Medicare Enrolled
Dr. Michael Desautel, MD
Urology Physician · Inverness, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Desautel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desautel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Desautel
Dr. Michael Desautel is an urology physician in Inverness, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Desautel performed 6,713 Medicare services across 3,745 unique beneficiaries.
Between the years covered by Open Payments, Dr. Desautel received a total of $16,108 from 28 pharmaceutical and/or device companies across 110 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Desautel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in FL
$16,108 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 78107 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗6,713
Medicare services
Top 18% in FL for urology physician
3,745
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~336 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,797 | $2 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,194 | $62 | $227 |
| Gadolinium MRI contrast injection Administration of a gadolinium-based contrast agent to enhance magnetic resonance imaging. The dose is measured per milliliter of the agent injected. |
586 | $1 | $3 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
495 | $6 | $6 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
379 | $8 | $26 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
373 | $90 | $320 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
328 | $48 | $159 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 300 | $3 | $8 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
194 | $38 | $142 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
186 | $60 | $207 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 118 | $133 | $336 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
86 | $113 | $422 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
71 | $39 | $98 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
65 | $76 | $283 |
| MRI of pelvis, without contrast A magnetic resonance imaging scan of the pelvic area performed without the use of contrast dye. |
64 | $90 | $240 |
| MRI of pelvis with and without contrast A magnetic resonance imaging scan of the pelvic area performed both before and after the administration of a contrast dye to enhance image detail. |
64 | $127 | $354 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
62 | $67 | $219 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
55 | $67 | $256 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
39 | $24 | $81 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
38 | $41 | $156 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
38 | $26 | $65 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
23 | $95 | $333 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
23 | $105 | $341 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
21 | $96 | $360 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
21 | $118 | $424 |
| Electronic analysis of implanted neurostimulator This procedure involves electronically analyzing an implanted neurostimulator generator and performing simple programming for spinal cord or peripheral nerve stimulation. |
21 | $38 | $125 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
18 | $53 | $183 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
15 | $18 | $170 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
14 | $334 | $1,061 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
13 | $554 | $1,770 |
| Insertion of temporary bladder tube | 12 | $33 | $114 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
22.8% medium
76.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,108
Total received (2018-2024)
Avg $2,301/year across 7 years
Top 14% in FL for urology physician
28
Companies
110
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$13,500 (83.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,508 (15.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$101
2023
$140
2022
$381
2021
$3,426
2020
$3,755
2019
$3,712
2018
$4,593
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Laser Specialty Medical, LLC
$13,500
Astellas Pharma US Inc
$850
Medtronic, Inc.
$326
Medtronic USA, Inc.
$301
Axonics, Inc.
$150
Teleflex LLC
$133
Boston Scientific Corporation
$101
Janssen Biotech, Inc.
$99
Endo Pharmaceuticals Inc.
$93
Cook Medical LLC
$86
PFIZER INC.
$75
Ferring Pharmaceuticals Inc.
$45
TOLMAR Pharmaceuticals, Inc.
$40
Avadel Specialty Pharmaceuticals, LLC
$38
Olympus America Inc.
$31
BOSTON SCIENTIFIC CORPORATION
$28
ROCHESTER MEDICAL CORPORATION
$22
NeoTract Inc.
$21
AbbVie, Inc.
$20
Coloplast Corp
$19
Rochester Medical Corporation
$18
Allergan Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$18
Dendreon Pharmaceuticals LLC
$17
DENTSPLY IH Inc.
$17
C. R. BARD, INC. & SUBSIDIARIES
$16
Myriad Genetic Laboratories, Inc.
$15
Allergan, Inc.
$12
Top 3 companies account for 91.1% of total payments
Associated products mentioned in payments ›
AMS · AMS 700 CXR RTE KIT · AVEED · Androgel · Axonics · BOTOX · BOTOX THERAPEUTIC · Bulkamid · CAPTURA PRO · COOK MEDICAL EXTRACTORS · Cook · Cook Medical Lasers · Cook Medical Urology · ELIGARD · ERLEADA · Erleada · FIRMAGON · GENERAL KIDNEY STONE DISEASE · INTERSTIM · LITHOVUE · LYNX · LoFric · MYRBETRIQ · NOCDURNA · NURO · Noctiva · PROVENGE · Prolaris · REZUM · TITAN · TOVIAZ · UroLift · UroLift System · XIAFLEX · XTANDI · Xofigo · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type.
Equivalent to $240 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
15
Per 100K population
9.5
County median income
$55,355
Nearest hospital
HCA FLORIDA CITRUS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Desautel is a clinical cardiology specialist, with above-average Medicare volume (top 18% in FL), with mixed engagement industry engagement in the top 14% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Desautel experienced with automated urinalysis?
Based on Medicare claims data, Dr. Desautel performed 1,797 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Desautel receive payments from pharmaceutical companies?
Yes. Dr. Desautel received a total of $16,108 from 28 companies across 110 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desautel's costs compare to other urology physicians in Inverness?
Dr. Desautel's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desautel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Inverness
Browse urology physicians in Inverness ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
Laser Specialty Medical, LLC Payments to Doctors
See all physicians who received payments from Laser Specialty Medical, LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology